AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Electromyographic Biofeedback Therapy in Patients With Dyssynergic Defecation

RecruitingNAAges 18 Years - 70 YearsAllKocaeli University
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

This study aimed to investigate the effects of game-based electromyographic (EMG) biofeedback therapy on the quality of life and sleep quality of individuals diagnosed with dyssynergic defecation.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: 1. Diagnosis of dyssynergic defecation was confirmed by anorectal manometry, which demonstrated paradoxical pelvic floor muscle contraction and/or inadequate relaxation during defecation. 2. Eligibility for a pelvic floor rehabilitation program was based on a comprehensive evaluation conducted at the Physical Medicine and Rehabilitation Clinic. 3. Age between 18 and 70 years. 4. A history of chronic constipation lasting at least six months, in accordance with the Rome IV diagnostic criteria. 5. Stool consistency was classified as type 1 or type 2 according to the Bristol Stool Scale, indicating a hard stool pattern. Exclusion Criteria: 1. Presence of communication barriers that may interfere with participation in the study. 2. Cognitive impairment affects the ability to comply with rehabilitation programs or assessments. 3. Pregnancy. 4. Presence of severe depression and/or anxiety disorder. 5. Untreated metabolic or endocrine disorders, including but not limited to diabetes mellitus, hypothyroidism, hypokalemia, and hypercalcemia. 6. Use of medications known to cause or exacerbate constipation. 7. History of spinal, rectal, or pelvic surgery, excluding cholecystectomy, hysterectomy, and appendectomy. 8. Presence of colorectal malignancy or inflammatory bowel disease. 9. Anorectal malformations or congenital pelvic floor anomalies. 10. Spina bifida, spinal cord injury, or neurological disorders, including multiple sclerosis, Parkinson's disease, dementia, or epilepsy. 11. Presence of severe cardiac or renal disease. 12. Advanced-stage hemorrhoids, anal fissures, or anal fistulas.
๐Ÿ’Š

What it tests

  • Game-Based Electromyographic (EMG) Biofeedback Therapy
  • Sham Control
๐Ÿ“

Where

1 site
Kocaeli University
Kocaeli, Turkey (Tรผrkiye)
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy